Haemonetics (HAE) revenue and earnings history
Haemonetics reported revenue of $1.33B for fiscal 2026 (year ended Mar 28, 2026), −2.0% on the year before, and net income of $97.3M.
Over 16 years, from fiscal 2010 to fiscal 2026, revenue grew at a compound rate of +4.6% a year.
Revenue and net income, 18 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026ended Mar 28, 2026 | $1.33B−2.0% | $157M | $97.3M | $293M | $32.8M | $260M | $33.8M | $245M | $1.24B | 10-K |
| 2025ended Mar 29, 2025 | $1.36B+4.0% | $222M | $168M |
The latest quarter, insider trades and fund moves: Haemonetics (HAE) on OQRO.
Common questions
What was Haemonetics's revenue in fiscal 2026?
$1.33B for the year ended Mar 28, 2026, as reported in its 10-K filed May 20, 2026. That is −2.0% on fiscal 2025 ($1.36B).
How fast has Haemonetics's revenue grown?
From $645M in fiscal 2010 to $1.33B in fiscal 2026: a compound annual growth rate of +4.6% over 16 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Haemonetics been profitable?
It reported a net loss in 2 of the years shown (2016, 2017). The highest net income was $168M in fiscal 2025.
Where these figures come from
The SEC’s companyfacts data: every figure Haemonetics tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
